Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Compass Therapeutics (CMPX) Revenue (2024)

Historic Revenue for Compass Therapeutics (CMPX) over the last 1 years, with Q2 2024 value amounting to $850000.0.

  • Compass Therapeutics' Revenue changed N/A to $850000.0 in Q2 2024 from the same period last year, while for Mar 2025 it was $850000.0, marking a year-over-year change of. This contributed to the annual value of $850000.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Compass Therapeutics reported Revenue of $850000.0 as of Q2 2024.
  • Compass Therapeutics' 5-year Revenue high stood at $850000.0 for Q2 2024, and its period low was $850000.0 during Q2 2024.